- Home
- NDRA vs PTIX Comparison
NDRA vs PTIX Comparison
Compare NDRA & PTIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NDRA
- PTIX
- Stock Information
- Founded
- NDRA 2007
- PTIX 1994
- Country
- NDRA United States
- PTIX United States
- Employees
- NDRA N/A
- PTIX N/A
- Industry
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- PTIX Biotechnology: Pharmaceutical Preparations
- Sector
- NDRA Health Care
- PTIX Health Care
- Exchange
- NDRA Nasdaq
- PTIX Nasdaq
- Market Cap
- NDRA 3.1M
- PTIX 2.7M
- IPO Year
- NDRA 2017
- PTIX 2016
- Fundamental
- Price
- NDRA $4.71
- PTIX $3.68
- Analyst Decision
- NDRA Strong Buy
- PTIX
- Analyst Count
- NDRA 1
- PTIX 0
- Target Price
- NDRA $46.00
- PTIX N/A
- AVG Volume (30 Days)
- NDRA 30.1K
- PTIX 8.3M
- Earning Date
- NDRA 11-14-2025
- PTIX 09-10-2025
- Dividend Yield
- NDRA N/A
- PTIX N/A
- EPS Growth
- NDRA N/A
- PTIX N/A
- EPS
- NDRA N/A
- PTIX N/A
- Revenue
- NDRA N/A
- PTIX N/A
- Revenue This Year
- NDRA N/A
- PTIX N/A
- Revenue Next Year
- NDRA N/A
- PTIX N/A
- P/E Ratio
- NDRA N/A
- PTIX N/A
- Revenue Growth
- NDRA N/A
- PTIX N/A
- 52 Week Low
- NDRA $2.90
- PTIX $2.25
- 52 Week High
- NDRA $22.68
- PTIX $15.26
- Technical
- Relative Strength Index (RSI)
- NDRA 52.93
- PTIX 57.32
- Support Level
- NDRA $4.00
- PTIX $2.79
- Resistance Level
- NDRA $5.28
- PTIX $3.39
- Average True Range (ATR)
- NDRA 0.34
- PTIX 0.24
- MACD
- NDRA 0.11
- PTIX 0.02
- Stochastic Oscillator
- NDRA 55.47
- PTIX 81.58
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
About PTIX Protagenic Therapeutics Inc.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.